Descrizione business
The Siegfried Group is a global life sciences company with facilities located in Switzerland, the USA, Malta, China, Germany and France. Siegfried is active in primary and secondary drug manufacturing. The company develops and manufactures active pharmaceutical ingredients for pharmaceutical clients with R& D programs, related intermediates and controlled substances. Siegfried also offers development and production of finished dosage forms, including sterile fillings.
Consiglio di amministrazione & Consiglio di sorveglianza
| CEO |
| Dr. Wolfgang Wienand |
| Consiglio di amministrazione |
| Dr. Reto Suter, Dr. Jürgen Roos, Irene Wosgien, Marcel Imwinkelried, Marianne Späne, Henrik Krüpper, Christian Dowdeswell |
| Consiglio di sorveglianza |
| Dr. Andreas Casutt, Alexandra Brand, Beat Walti, Dr. Martin Schmid, Isabelle Welton, Wolfram Carius, Elodie Carr-Cingari |
Dati aziendali
| Name: |
Siegfried Holding AG |
| Indirizzo: |
Untere Brühlstraße 4,CH-4800 Zofingen |
| Telefono: |
+41-62-746-1111 |
| Fax: |
+41-62-746-1202 |
| E-mail: |
info@siegfried.ch
|
| Internet: |
www.siegfried.ch |
| Industria: |
Commodities |
| Settore: |
Chemicals |
| Sub settore: |
- |
| Fine dell'anno finanziario: |
31/12 |
| Flottante libero: |
75.10% |
| Data dell'IPO: |
- |
Rapporti con gli investitori
| Name: |
Reto Suter |
| IR telefono: |
+41-62-746-15-35 |
| IR Fax: |
- |
| IR e-mail: |
reto.suter@siegfried.ch
|
